JP2009506762A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506762A5 JP2009506762A5 JP2008528437A JP2008528437A JP2009506762A5 JP 2009506762 A5 JP2009506762 A5 JP 2009506762A5 JP 2008528437 A JP2008528437 A JP 2008528437A JP 2008528437 A JP2008528437 A JP 2008528437A JP 2009506762 A5 JP2009506762 A5 JP 2009506762A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cell
- nucleic acid
- seq
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 34
- 206010028980 Neoplasm Diseases 0.000 claims 17
- 210000004027 cell Anatomy 0.000 claims 15
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 12
- 150000007523 nucleic acids Chemical class 0.000 claims 12
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 11
- 108091008874 T cell receptors Proteins 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 239000013604 expression vector Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 7
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims 6
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 1
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 1
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 229940022399 cancer vaccine Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940047120 colony stimulating factors Drugs 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 108010028930 invariant chain Proteins 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05019255A EP1760089B1 (en) | 2005-09-05 | 2005-09-05 | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
| EP05019255.8 | 2005-09-05 | ||
| PCT/EP2006/008641 WO2007028573A1 (en) | 2005-09-05 | 2006-09-05 | Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506762A JP2009506762A (ja) | 2009-02-19 |
| JP2009506762A5 true JP2009506762A5 (enExample) | 2009-07-16 |
| JP5132561B2 JP5132561B2 (ja) | 2013-01-30 |
Family
ID=35149455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528437A Expired - Fee Related JP5132561B2 (ja) | 2005-09-05 | 2006-09-05 | ヒト白血球抗原（ｈｌａ）クラスｉまたはｉｉ分子に結合する腫瘍関連ペプチドおよび関連する抗癌ワクチン |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090274714A1 (enExample) |
| EP (2) | EP1760089B1 (enExample) |
| JP (1) | JP5132561B2 (enExample) |
| KR (1) | KR101150663B1 (enExample) |
| CN (1) | CN101287755B (enExample) |
| AT (2) | ATE440107T1 (enExample) |
| AU (1) | AU2006289289B2 (enExample) |
| BR (1) | BRPI0615466A2 (enExample) |
| CA (1) | CA2621414C (enExample) |
| CY (2) | CY1110536T1 (enExample) |
| DE (2) | DE602005016112D1 (enExample) |
| DK (2) | DK1760089T3 (enExample) |
| EA (1) | EA013466B1 (enExample) |
| ES (2) | ES2330013T3 (enExample) |
| HR (1) | HRP20110240T1 (enExample) |
| NO (1) | NO20081690L (enExample) |
| NZ (1) | NZ565956A (enExample) |
| PL (2) | PL1760089T3 (enExample) |
| PT (2) | PT1760089E (enExample) |
| RS (1) | RS51893B (enExample) |
| SI (2) | SI1760089T1 (enExample) |
| UA (2) | UA97095C2 (enExample) |
| WO (1) | WO2007028573A1 (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005020046D1 (de) | 2005-09-05 | 2010-04-29 | Immatics Biotechnologies Gmbh | Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| ES2321680B1 (es) * | 2007-04-26 | 2010-03-05 | Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental - Alejandro Otero (Fibao) | Restauracion de las moleculas hla de clase i mediante terapia genica empleando vectores adenovirales portando el gen de la beta 2-microglobulina. |
| NZ582823A (en) * | 2007-07-27 | 2012-04-27 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| RS54204B1 (sr) | 2007-07-27 | 2015-12-31 | Immatics Biotechnologies Gmbh | Nova imunoterapija protiv tumora mozga |
| HUE025636T2 (en) | 2007-07-27 | 2016-04-28 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
| CY1112212T1 (el) * | 2008-04-24 | 2015-12-09 | Immatics Biotechnologies Gmbh | Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια |
| EP2113253B1 (en) * | 2008-04-30 | 2010-03-31 | Immatics Biotechnologies GmbH | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
| PT2119726E (pt) | 2008-05-14 | 2015-03-30 | Immatics Biotechnologies Gmbh | Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano |
| ES2536465T3 (es) * | 2008-10-01 | 2015-05-25 | Immatics Biotechnologies Gmbh | Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres |
| AU2016204712B2 (en) * | 2008-10-01 | 2018-03-01 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201009222D0 (en) * | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| TWI618541B (zh) * | 2010-12-02 | 2018-03-21 | 腫瘤療法 科學股份有限公司 | Ｔｏｍｍ３４胜肽與含此胜肽之疫苗 |
| ES2647768T3 (es) * | 2011-07-05 | 2017-12-26 | Cadila Pharmaceuticals Limited | Antígeno de cáncer |
| MY170949A (en) * | 2011-07-11 | 2019-09-20 | Cancer Res Initiatives Foundation | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| AU2013280416B2 (en) | 2012-06-27 | 2017-06-15 | Rutgers, The State University Of New Jersey | Rapid assays for T-cell activation by RNA measurements using flow cytometry |
| US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
| TWI714869B (zh) * | 2013-08-05 | 2021-01-01 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| BR112016013138A2 (pt) | 2013-12-09 | 2018-01-16 | Targovax Asa | mistura de peptídeos |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| MA50819A (fr) | 2014-12-23 | 2021-04-07 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers |
| DK3271382T3 (da) * | 2015-03-16 | 2020-05-04 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| CR20210232A (es) | 2015-03-17 | 2022-06-24 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVA COMBINACIÓN DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA CONTRA EL CÁNCER DE PÁNCREAS Y OTROS TIPOS DE CÁNCER (Divisional 2017-0419) |
| IL301919A (en) | 2015-03-27 | 2023-06-01 | Immatics Biotechnologies Gmbh | Innovative peptides and a combination of peptides for use in immunotherapy against various tumors |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| GB201505585D0 (en) | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| IL292697A (en) | 2015-06-19 | 2022-07-01 | Immatics Biotechnologies Gmbh | New peptides and their combination for use in immunotherapy and methods for creating supports for use against pancreatic cancer and other types of cancer |
| GB201510771D0 (en) * | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| HK1254866A1 (zh) | 2015-06-25 | 2019-07-26 | Immatics Biotechnologies Gmbh | 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物 |
| IL308735A (en) | 2015-07-01 | 2024-01-01 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201511792D0 (en) | 2015-07-06 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers |
| PT3319985T (pt) | 2015-07-06 | 2021-01-06 | Immatics Biotechnologies Gmbh | Novos péptidos e combinação de péptidos para uso em imunoterapia do cancro do esófago e outros cancros |
| GB201512369D0 (en) | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| PH12022551111A1 (en) | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201517538D0 (en) | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| EP3167898A1 (en) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Method for obtaining tumor peptides and uses thereof |
| WO2017096247A1 (en) * | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
| MY196837A (en) | 2015-12-11 | 2023-05-03 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| GB201521894D0 (en) * | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| AU2017222461A1 (en) * | 2016-02-22 | 2018-08-30 | Oceanside Biotechnology | Neoantigen compositions and methods of using the same in immunooncotherapy |
| SG11201808196UA (en) * | 2016-03-31 | 2018-10-30 | Neon Therapeutics Inc | Neoantigens and methods of their use |
| TW202304970A (zh) * | 2016-08-26 | 2023-02-01 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| CN106986932A (zh) * | 2017-04-06 | 2017-07-28 | 海口市人民医院 | 一种c‑Met表位肽及其应用 |
| SG11202007750PA (en) * | 2018-02-15 | 2020-09-29 | National Univ Corporation Asahikawa Medical Univ | Cancer antigen peptide |
| MX2021002333A (es) * | 2018-08-30 | 2021-04-28 | Univ Montreal | Metodo basado en proteogenomica para identificar antigenos especificos de tumores. |
| CN110804642B (zh) * | 2019-09-10 | 2022-06-21 | 清华大学 | Gpr174免疫学功能及其用途 |
| KR20220100664A (ko) * | 2019-11-14 | 2022-07-15 | 보가지치 유니버시테시 | 암 면역요법에서의 asc speck |
| CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术（广东）有限公司 | 源自于ssx2抗原的短肽 |
| US20240358808A1 (en) * | 2021-04-23 | 2024-10-31 | Flow Pharma, Inc. | Vaccine for sars-cov-2 |
| CN118580322A (zh) * | 2022-01-05 | 2024-09-03 | 成都朗谷生物科技股份有限公司 | 针对乙型肝炎病毒的抗原肽 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| YU44186B (en) | 1978-12-22 | 1990-04-30 | Biogen Nv | Process for obtaining recombinant dnk molecules |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| WO1996003144A1 (en) | 1994-07-27 | 1996-02-08 | The Council Of The Queensland Institute Of Medical Research | Polyepitope vaccines |
| US6805861B2 (en) | 1996-01-17 | 2004-10-19 | Imperial College Innovations Limited | Immunotherapy using cytotoxic T lymphocytes (CTL) |
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| KR100358068B1 (ko) * | 1999-12-28 | 2002-10-25 | 주식회사 하이닉스반도체 | 플래쉬 메모리 소자의 제조방법 |
| WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| US20060045881A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
-
2005
- 2005-09-05 SI SI200530796T patent/SI1760089T1/sl unknown
- 2005-09-05 EP EP05019255A patent/EP1760089B1/en not_active Expired - Lifetime
- 2005-09-05 PL PL05019255T patent/PL1760089T3/pl unknown
- 2005-09-05 AT AT05019255T patent/ATE440107T1/de active
- 2005-09-05 DK DK05019255T patent/DK1760089T3/da active
- 2005-09-05 PT PT05019255T patent/PT1760089E/pt unknown
- 2005-09-05 ES ES05019255T patent/ES2330013T3/es not_active Expired - Lifetime
- 2005-09-05 DE DE602005016112T patent/DE602005016112D1/de not_active Expired - Lifetime
-
2006
- 2006-09-05 CA CA2621414A patent/CA2621414C/en not_active Expired - Fee Related
- 2006-09-05 WO PCT/EP2006/008641 patent/WO2007028573A1/en not_active Ceased
- 2006-09-05 SI SI200630949T patent/SI1922334T1/sl unknown
- 2006-09-05 UA UAA200803781A patent/UA97095C2/ru unknown
- 2006-09-05 US US12/065,725 patent/US20090274714A1/en not_active Abandoned
- 2006-09-05 CN CN200680038407.7A patent/CN101287755B/zh not_active Expired - Fee Related
- 2006-09-05 KR KR1020087008126A patent/KR101150663B1/ko not_active Expired - Fee Related
- 2006-09-05 UA UAA201111468A patent/UA105210C2/ru unknown
- 2006-09-05 RS RS20110146A patent/RS51893B/sr unknown
- 2006-09-05 AT AT06777167T patent/ATE494303T1/de active
- 2006-09-05 AU AU2006289289A patent/AU2006289289B2/en not_active Ceased
- 2006-09-05 BR BRPI0615466-2A patent/BRPI0615466A2/pt not_active IP Right Cessation
- 2006-09-05 JP JP2008528437A patent/JP5132561B2/ja not_active Expired - Fee Related
- 2006-09-05 PL PL06777167T patent/PL1922334T3/pl unknown
- 2006-09-05 ES ES06777167T patent/ES2358802T3/es active Active
- 2006-09-05 DK DK06777167.5T patent/DK1922334T3/da active
- 2006-09-05 DE DE602006019446T patent/DE602006019446D1/de active Active
- 2006-09-05 EA EA200800676A patent/EA013466B1/ru not_active IP Right Cessation
- 2006-09-05 HR HR20110240T patent/HRP20110240T1/xx unknown
- 2006-09-05 NZ NZ565956A patent/NZ565956A/en not_active IP Right Cessation
- 2006-09-05 PT PT06777167T patent/PT1922334E/pt unknown
- 2006-09-05 EP EP06777167A patent/EP1922334B1/en active Active
-
2008
- 2008-04-04 NO NO20081690A patent/NO20081690L/no not_active Application Discontinuation
-
2009
- 2009-10-08 CY CY20091101040T patent/CY1110536T1/el unknown
-
2011
- 2011-03-11 CY CY20111100271T patent/CY1113062T1/el unknown